Effect of combined farnesoid X receptor agonist and angiotensin II type 1 receptor blocker on ongoing hepatic fibrosis

发表于 2026-8-1 10:34:04

期刊：Indian Journal of Gastroenterology

文献作者：Tadashi Namisaki; Kosuke Kaji; Naotaka Shimozato; Daisuke Kaya; Takahiro Ozutsumi; Yuki Tsuji; Yukihisa Fujinaga; Koh Kitagawa; Masanori Furukawa; Shinya Sato; Yasuhiko Sawada; Norihisa Nishimura; Hiroaki Takaya; Yasushi Okura; Kenichiro Seki; Hideto Kawaratani; Kei Moriya; Ryuichi Noguchi; Kiyoshi Asada; Takemi Akahane; Akira Mitoro; Hitoshi Yoshiji

出版日期：2022-4-

DOI号：10.1007/s12664-021-01220-5

下载链接：https://link.springer.com/conten ... 664-021-01220-5.pdf

文献链接：https://doi.org/10.1007/s12664-021-01220-5

当前文献来源于 Springer Science and Business Media LLC。

备注信息：

发表于 2026-8-1 10:34:05

: 当前求助已完成，请重新发起求助。
已完结状态的附件将会在24小时内删除。

[Springer] Effect of combined farnesoid X receptor agonist and angiotensin II type 1 receptor blocker on ongoing hepatic fibrosis

已采纳

同分类求助

最新回复

站点公告

今日热心研友

（热心研友QQ群）

[Springer] Effect of combined farnesoid X receptor agonist and angiotensin II type 1 receptor blocker on ongoing hepatic fibrosis 一键复制

已采纳